Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Neoplasms unspecified malignancy and site unspecified NEC
ADR ID BADD_A03014
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.02      Neoplasms unspecified malignancy and site unspecified NEC
Description Not Available
MedDRA Code 10029111
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D02392Zoledronic acid
BADD_D02393Zolmitriptan
BADD_D02401Coenzyme m
BADD_D02406Radium ra 223 dichloride
BADD_D02412Octreotide
BADD_D02419Rosiglitazone
BADD_D02434Cinacalcet
BADD_D02436Atorvastatin
BADD_D02443Tiotropium
BADD_D02459Dalteparin
BADD_D02461Lanreotide
BADD_D02464Fingolimod
BADD_D02470Nintedanib
BADD_D02476Polyethylene glycol
BADD_D02480Alectinib
BADD_D02483Ribociclib
BADD_D02485Talazoparib
BADD_D02486Niraparib
BADD_D02503Telotristat ethyl
BADD_D02504Lorlatinib
BADD_D02509Brigatinib
BADD_D02510Rucaparib
BADD_D02524Ivosidenib
The 10th Page    First    Pre   10    Total 10 Pages